Preferred method of communication
Research and teaching
Area of Focus
- Genitourinary and cutaneous malignancies
Summary of Research
Dr. Cheng is an expert in melanoma, testicular germ cell cancer, and other GU cancers. She is recognized as a national expert in immune-oncology and a productive clinical trialist. She has led two multi-centre clinical trials in Canada and has contributed to several key oncology drug developments in recent years. Her key research interest is in the area of immunotherapy for cancers, especially melanoma focusing on disease characteristics, treatment outcome, and clinical and biological predictors for response and toxicity. She is experienced in database research and translational research. Currently, she is investigating UV-mediated melanomagenesis and molecular signatures of UV mutagenesis.
Dr. Cheng completed her MD at Beijing Medical University, Beijing, China in 1987 and MSc. at the University of Calgary in Molecular Oncology in 1991. She obtained board certification in Internal Medicine in 2001 and Medical Oncology in 2003 at the University of Calgary. Dr. Cheng joined the Tom Baker Cancer Centre in 2003 subspecialized in Cutaneous and GU cancers.